Diagnosis and management of tumors of the adrenal medulla

Hormone and Metabolic Research

Volumn 37, Issue 12, 2005, Pages 717-721

  Ilias, Ioannis ^a   Pacak, K ^b  

^a UNIVERSITY OF PATRAS   (Greece)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Laparoscopy; Metanephrines; Neuroblastoma; Paraganglioma; Pheochromocytoma; Radionuclide imaging; Surgery

Indexed keywords

(3 IODOBENZYL)GUANIDINE; DOPA; DOPAMINE; FLUORINE 18; HOMOVANILLIC ACID; IODINE 123; METADRENALIN; NORADRENALIN; VANILMANDELIC ACID;

ADRENAL MEDULLA TUMOR; ADRENERGIC SYSTEM; BRAIN TUMOR; CHEMICAL ANALYSIS; CHEMOTHERAPY; CHROMAFFIN CELL; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; MEASUREMENT; NEUROBLASTOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT; PHEOCHROMOCYTOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SCINTIGRAPHY; SIPPLE SYNDROME; SURVIVAL; VON HIPPEL LINDAU DISEASE;

ADRENAL GLAND NEOPLASMS; ADRENAL MEDULLA; HUMANS; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A; NEUROBLASTOMA; NEUROENDOCRINE TUMORS; PHEOCHROMOCYTOMA; PROGNOSIS;

EID: 29744448577     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-921091     Document Type: Review

References (39)

1. Bornstein SR, Oelkers W. Adrenal function and metabolism. Horm Metab Res 2004; 36: 341-345
2. Lack EE. Tumors of the adrenal gland and extra-adrenal paraganglia. Washington DC: Armed Forces Institute of Pathology, 1997
3. Eisenhofer G, Lenders JW, Pacak K. Biochemical diagnosis of pheochromocytoma. Front Horm Res 2004; 31: 76-106
4. Ilias I, Shulkin B, Pacak K. New functional imaging modalities for chromaffin tumors, neuroblastomas and ganglioneuromas. Trends Endocrinol Metab 2005; 16: 66-72
5. van den Berg R. Imaging and management of head and neck paragangliomas. Eur Radiol 2005; 15: 1310-1318
6. Neumann HP, Bausch B, McWhinney SR, Bender BU, Gimm O, Franke G, Schipper J, Klisch J, Altehoefer C, Zerres K, Januszewicz A, Eng C, Smith WM, Munk R, Manz T, Glaesker S, Apel TW, Treier M, Reineke M, Walz MK, Hoang-Vu C, Brauckhoff M, Klein-Franke A, Klose P, Schmidt H, Maier-Woelfle M, Peczkowska M, Szmigielski C, Eng C. Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med 2002; 346: 1459-1466
7. Eisenhofer G, Goldstein DS, Walther MM, Friberg P, Lenders JW, Keiser HR, Pacak K. Biochemical diagnosis of pheochromocytoma: how to distinguish true- from false-positive test results. J Clin Endocrinol Metab 2003; 88: 2656-2666
8. Pacak K, Ilias I, Adams KT, Eisenhofer G. Biochemical diagnosis, localization and management of pheochromocytoma: focus on multiple endocrine neoplasia type 2 in relation to other hereditary syndromes and sporadic forms of the tumour. J Intern Med 2005; 257: 60-68
9. Argiris A, Mellott A, Spies S. PET scan assessment of chemotherapy response in metastatic paraganglioma. Am J Clin Oncol 2003; 26: 563-566
10. Neumann HP, Cybulla M, Shibata H, Oya M, Naruse M, Higashihara E, Terachi T, Ling H, Takami H, Shuin T, Murai M. New genetic causes of pheochromocytoma: current concepts and the clinical relevance. Keio J Med 2005; 54: 15-21
11. Boedeker CC, Ridder GJ, Schipper J. Paragangliomas of the head and neck: diagnosis and treatment. Fam Cancer 2005; 4: 55-59
12. Pacak K, Linehan WM, Eisenhofer G, Walther MM, Goldstein DS. Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma. Ann Intern Med 2001; 134: 315-329
13. Beltsevich DG, Kuznetsov NS, Kazaryan AM, Lysenko MA. Pheochromocytoma surgery: epidemiologic peculiarities in children. World J Surg 2004; 28: 592-596
14. Elder EE, Elder G, Larsson C. Pheochromocytoma and functional paraganglioma syndrome: no longer the 10% tumor. J Surg Oncol 2005; 89: 193-201
15. Brink I, Hoegerle S, Klisch J, Bley TA. Imaging of pheochromocytoma and paraganglioma. Fam Cancer 2005; 4: 61-68
16. Elsayes KM, Narra VR, Leyendecker JR, Francis IR, Lewis JS Jr, Brown JJ. MRI of adrenal and extraadrenal pheochromocytoma. AJR - Am J Roentgenol 2005; 184: 860-867
17. Beck O, Fassbender WJ, Beyer P, Kriener S, Neumann HP, Klingebiel T, Lehrnbecher T. Pheochromocytoma in childhood: implication for further diagnostic procedures. Acta Paediatr 2004; 93: 1630-1634
18. Opocher G, Conton P, Schiavi F, Macino B, Mantero F. Pheochromocytoma in von Hippel-Lindau disease and neurofibromatosis type 1. Fam Cancer 2005; 4: 13-16
19. Kaltsas GA, Papadogias D, Grossman AB. The clinical presentation (symptoms and signs) of sporadic and familial chromaffin cell tumours (phaeochromocytomas and paragangliomas). Front Horm Res 2004; 31: 61-75
20. Lee KL, Ma JF, Shortliffe LD. Neuroblastoma: management, recurrence, and follow-up. Urol Clin North Am 2003; 30: 881-890
21. Morgenstern BZ, Krivoshik AP, Rodriguez V, Anderson PM. Wilms' tumor and neuroblastoma. Acta Paediatr Suppl 2004; 93: 78-84
22. Eisenhofer G, Lenders JW, Goldstein DS, Mannelli M, Csako G, Walther MM, Brouwers FM, Pacak K. Pheochromocytoma Catecholamine Phenotypes and Prediction of Tumor Size and Location by Use of Plasma Free Metanephrines. Clin Chem 2005; 51: 735-744
23. Eisenhofer G, Goldstein DS, Sullivan P, Csako G, Brouwers FM, Lai EW, Adams KT, Pacak K. Biochemical and clinical manifestations of dopamine-producing paragangliomas: utility of plasma methoxytyramine. J Clin Endocrinol Metab 2005; 90: 2068-2075
24. Ilias I, Pacak K. Current approaches and recommended algorithm for the diagnostic localization of pheochromocytoma. J Clin Endocrinol Metab 2004; 89: 479-491
25. Ilias I, Alesci S, Pacak K. Current views on imaging of adrenal tumors. Horm Metab Res 2004; 36: 430-435
26. Kann PH. Endoscopic ultrasound imaging of the adrenals. Endoscopy 2005; 37: 244-253
27. Kann PH, Wirkus B, Behr T, Klose KJ, Meyer S. Endosonographic imaging of benign and malignant pheochromocytomas. J Clin Endocrinol Metab 2004; 89: 1694-1697
28. Taieb D, Sebag F, Hubbard JG, Mundler O, Henry JF, Conte-Devolx B. Does iodine-131 meta-iodobenzylguanidine (MIBG) scintigraphy have an impact on the management of sporadic and familial phaeochromocytoma? Clin Endocrinol (Oxf) 2004; 61: 102-108
29. Sturgeon C, Kebebew E. Laparoscopic adrenalectomy for malignancy. Surg Clin North Am 2004; 84: 755-774
30. Diner EK, Franks ME, Behari A, Linehan WM, Walther MM. Partial Adrenalectomy: The National Cancer Institute Experience. Urology, in press (doi:10.1016/j.urology.2005.01.009)
31. Yip L, Lee JE, Shapiro SE, Waguespack SG, Sherman SI, Hoff AO, Gagel RF, Arens JF, Evans DB. Surgical management of hereditary pheochromocytoma. J Am Coll Surg 2004; 198: 525-534
32. Neumann HPH, Reincke M, Bender BU, Elsner R, Janetschek G. Preserved Adrenocortical Function After Laparoscopic Bilateral Adrenal Sparing Surgery for Hereditary Pheochromocytoma. J Clin Endocrinol Metab 1999; 84: 2608-2610
33. Nambirajan T, Leeb K, Neumann HP, Graubner UB, Janetschek G. Laparoscopic adrenal surgery for recurrent tumours in patients with hereditary phaeochromocytoma. Eur Urol 2005; 47: 622-626
34. Brauckhoff M, Gimm O, Brauckhoff K, Dralle H. Repeat adrenocortical- sparing adrenalectomy for recurrent hereditary pheochromocytoma. Surg Today 2004; 34: 251-255
35. Sandoval C, Strom K, Stringel G. Laparoscopy in the management of pediatric intraabdominal tumors. JSLS - J Soc Laparoend Surg 2004; 8: 115-118
36. Hwang J, Shoaf G, Uchio EM, Watson J, Pacak K, Linehan WM, Walther MM. Laparoscopic management of extra-adrenal pheochromocytoma. J Urol 2004; 171: 72-76
37. Brouwers FM, Lenders JW, Eisenhofer G, Pacak K. Pheochromocytoma as an endocrine emergency. Rev Endocr Metab Disord 2003; 4: 121-128
38. John H, Ziegler WH, Hauri D, Jaeger P. Pheochromocytomas: can malignant potential be predicted? Urology 1999; 53: 679-683
39. Amar L, Servais A, Gimenez-Roqueplo AP, Zinzindohoue F, Chatellier G, Plouin PF. Year of Diagnosis, Features at Presentation, and Risk of Recurrence in Patients with Pheochromocytoma or Secreting Paraganglioma. J Clin Endocrinol Metab 2005; 90: 2110-2116